The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Due to its catalytically inactive nature, modifications of gene expression caused by dCas9 are transient, since the genomic DNA is not altered.
“Due to its catalytically inactive nature, modifications of gene expression caused by dCas9 are transient, since the genomic DNA is not altered [61,77].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [61]
The Introduction says dCas9’s mutations abolish DNA cleavage without impairing DNA binding, and the Results attribute repression to that binding rather than DNA editing. The Discussion reports that repression can be reversed when an inducer is withdrawn, but it does not establish that dCas9-mediated expression changes are always transient; reversibility there depends on withdrawing the inducer. Page numbers were not available in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measuredBy introducing two mutations in the RuvC and HNH catalytic domains of Cas9, scientists engineered a 'dead' Cas9 (dCas9) that could still bind to DNA but had no cleaving activity.
“By introducing two mutations in the RuvC and HNH catalytic domains of Cas9, scientists engineered a ‘dead’ Cas9 (dCas9) that could still bind to DNA but had no cleaving activity [61].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [61]
Bikard et al. demonstrated that CRISPR could be used as a new tool to regulate gene expression by either activating or repressing the transcription of bacterial genes.
“Later in the same year, Bikard et al. demonstrated how CRISPR could be used as a new tool to regulate gene expression by either activating or repressing the transcription of bacterial genes [61].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [61]
When both RuvC and HNH catalytic domains of Cas9 are modified through two silencing mutations, the system loses DNA cleaving capabilities but retains ability to bind targeted sequences.
“When both RuvC and HNH catalytic domains of Cas9 are modified through two silencing mutations, the system loses its DNA cleaving capabilities but retains the ability to bind to targeted sequences [61,77].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Self-citationRNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
Efficient genome editing in zebrafish using a CRISPR-Cas system
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J.-R. J., & Joung, J. K. (2013) · Nature Biotechnology · doi:10.1038/nbt.2501 · Cited by 2,937
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
RNA-programmed genome editing in human cells
Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., & Doudna, J. (2013) · eLife · doi:10.7554/elife.00471 · Cited by 2,098
RNA-guided genetic silencing systems in bacteria and archaea
Wiedenheft, B., Sternberg, S. H., & Doudna, J. A. (2012) · Nature · doi:10.1038/nature10886 · Cited by 1,851
Flagged first, then by citations
Research works printed but not linked: 36
- Auslander, 2012, From gene switches to mammalian designer cells: present and future prospects, Trends Biotechnol., 31, 155, 10.1016/j.tibtech.2012.11.006 · DOI
- Khalil, 2012, A synthetic biology framework for programming eukaryotic transcription functions, Cell, 150, 647, 10.1016/j.cell.2012.05.045 · DOI
- Beerli, 1998, Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks, Proc. Natl Acad. Sci. USA, 95, 14628, 10.1073/pnas.95.25.14628 · DOI
- Cong, 2012, Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains, Nat. Commun., 3, 968, 10.1038/ncomms1962 · DOI
- Miller, 2011, A TALE nuclease architecture for efficient genome editing, Nat. Biotechnol., 29, 143, 10.1038/nbt.1755 · DOI · Paper page
- Zhang, 2011, Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription, Nat. Biotechnol., 29, 149, 10.1038/nbt.1775 · DOI · Paper page
- Gasiunas, 2012, Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria, Proc. Natl Acad. Sci. USA, 109, E2579, 10.1073/pnas.1208507109 · DOI · Paper page
- Westra, 2012, CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3, Mol. Cell, 46, 595, 10.1016/j.molcel.2012.03.018 · DOI
- Bikard, 2012, Innate and adaptive immunity in bacteria: mechanisms of programmed genetic variation to fight bacteriophages, Curr. Opin. Immunol., 24, 15, 10.1016/j.coi.2011.10.005 · DOI
- Fineran, 2012, Memory of viral infections by CRISPR-Cas adaptive immune systems: acquisition of new information, Virology, 434, 202, 10.1016/j.virol.2012.10.003 · DOI
- Westra, 2012, The CRISPRs, they are a-changin': how prokaryotes generate adaptive immunity, Annu. Rev. Genet., 46, 311, 10.1146/annurev-genet-110711-155447 · DOI
- Brouns, 2008, Small CRISPR RNAs guide antiviral defense in prokaryotes, Science, 321, 960, 10.1126/science.1159689 · DOI · Paper page
- Carte, 2008, Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes, Genes Dev., 22, 3489, 10.1101/gad.1742908 · DOI
- Hatoum-Aslan, 2011, Mature clustered, regularly interspaced, short palindromic repeats RNA (crRNA) length is measured by a ruler mechanism anchored at the precursor processing site, Proc. Natl Acad. Sci. USA, 108, 21218, 10.1073/pnas.1112832108 · DOI · Paper page
- Haurwitz, 2010, Sequence- and structure-specific RNA processing by a CRISPR endonuclease, Science, 329, 1355, 10.1126/science.1192272 · DOI
- Garneau, 2010, The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA, Nature, 468, 67, 10.1038/nature09523 · DOI
- Hale, 2009, RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex, Cell, 139, 945, 10.1016/j.cell.2009.07.040 · DOI · Paper page
- Makarova, 2011, Evolution and classification of the CRISPR-Cas systems, Nat. Rev. Microbiol., 9, 467, 10.1038/nrmicro2577 · DOI · Paper page
- Deveau, 2008, Phage response to CRISPR-encoded resistance in Streptococcus thermophilus, J. Bacteriol., 190, 1390, 10.1128/JB.01412-07 · DOI
- Cho, 2013, Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease, Nat. Biotechnol., 31, 230, 10.1038/nbt.2507 · DOI · Paper page
- Dove, 1998, Conversion of the omega subunit of Escherichia coli RNA polymerase into a transcriptional activator or an activation target, Genes Dev., 12, 745, 10.1101/gad.12.5.745 · DOI
- Horton, 1993, In vitro recombination and mutagenesis of DNA : SOEing together tailor-made genes, Methods Mol. Biol., 15, 251
- Demarre, 2005, A new family of mobilizable suicide plasmids based on broad host range R388 plasmid (IncW) and RP4 plasmid (IncPalpha) conjugative machineries and their cognate Escherichia coli host strains, Res. Microbiol., 156, 245, 10.1016/j.resmic.2004.09.007 · DOI
- Chaveroche, 2000, A rapid method for efficient gene replacement in the filamentous fungus Aspergillus nidulans, Nucleic Acids Res., 28, E97, 10.1093/nar/28.22.e97 · DOI
- Husmann, 1995, Expression of the Arp protein, a member of the M protein family, is not sufficient to inhibit phagocytosis of Streptococcus pyogenes, Infect. Immun., 63, 345, 10.1128/IAI.63.1.345-348.1995 · DOI
- Gibson, 2009, Enzymatic assembly of DNA molecules up to several hundred kilobases, Nat. Methods, 6, 343, 10.1038/nmeth.1318 · DOI
- Cormack, 1996, FACS-optimized mutants of the green fluorescent protein (GFP), Gene, 173, 33, 10.1016/0378-1119(95)00685-0 · DOI
- Lutz, 1997, Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements, Nucleic Acids Res., 25, 1203, 10.1093/nar/25.6.1203 · DOI
- Zahner, 2000, The Streptococcus pneumoniae beta-galactosidase is a surface protein, J. Bacteriol., 182, 5919, 10.1128/JB.182.20.5919-5921.2000 · DOI
- Keasling, 1999, Gene-expression tools for the metabolic engineering of bacteria, Trends Biotechnol., 17, 452, 10.1016/S0167-7799(99)01376-1 · DOI
- Hannon, 2004, Unlocking the potential of the human genome with RNA interference, Nature, 431, 371, 10.1038/nature02870 · DOI
- Na, 2013, Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs, Nat. Biotechnol., 31, 170, 10.1038/nbt.2461 · DOI
- Chang, 2011, Non-contiguous finished genome sequence and contextual data of the filamentous soil bacterium Ktedonobacter racemifer type strain (SOSP1-21), Stand. Genomic. Sci., 5, 97, 10.4056/sigs.2114901 · DOI
- Gerdes, 2003, Experimental determination and system level analysis of essential genes in Escherichia coli MG1655, J. Bacteriol., 185, 5673, 10.1128/JB.185.19.5673-5684.2003 · DOI
- Zegans, 2009, Interaction between bacteriophage DMS3 and host CRISPR region inhibits group behaviors of Pseudomonas aeruginosa, J. Bacteriol., 191, 210, 10.1128/JB.00797-08 · DOI
- Libby, 2012, Membrane protein expression triggers chromosomal locus repositioning in bacteria, Proc. Natl Acad. Sci. USA, 109, 7445, 10.1073/pnas.1109479109 · DOI
Cited by
Sorted by citations
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Base editing: precision chemistry on the genome and transcriptome of living cells
Rees, H. A., & Liu, D. R. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0059-1 · Cited by 1,675
High-throughput functional genomics using CRISPR-Cas9
Shalem, O., Sanjana, N. E., & Zhang, F. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3899 · Cited by 1,233
Self-citationCas9 as a versatile tool for engineering biology
Mali, P., Esvelt, K. M., & Church, G. M. (2013) · Nature Methods · doi:10.1038/nmeth.2649 · Cited by 1,197
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
Bikard, D., Euler, C. W., Jiang, W., Nussenzweig, P. M., Goldberg, G. W., Duportet, X., Fischetti, V. A., & Marraffini, L. A. (2014) · Nature Biotechnology · doi:10.1038/nbt.3043 · Cited by 986
Self-citationBeyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation
Dominguez, A. A., Lim, W. A., & Qi, L. S. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.2 · Cited by 832
Orthogonal Cas9 proteins for RNA-guided gene regulation and editing
Esvelt, K. M., Mali, P., Braff, J. L., Moosburner, M., Yaung, S. J., & Church, G. M. (2013) · Nature Methods · doi:10.1038/nmeth.2681 · Cited by 786
In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9
Swiech, L., Heidenreich, M., Banerjee, A., Habib, N., Li, Y., Trombetta, J., Sur, M., & Zhang, F. (2015) · Nature Biotechnology · doi:10.1038/nbt.3055 · Cited by 772
Self-citationRock, J. M., Hopkins, F. F., Chavez, A., Diallo, M., Chase, M. R., Gerrick, E. R., Pritchard, J. R., Church, G. M., Rubin, E. J., Sassetti, C. M., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.274 · Cited by 538
Wang, H.-X., Li, M., Lee, C. M., Chakraborty, S., Kim, H.-W., Bao, G., & Leong, K. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00799 · Cited by 560
Ishino, Y., Krupovic, M., & Forterre, P. (2018) · Journal of Bacteriology · doi:10.1128/jb.00580-17 · Cited by 558
Classification and evolution of type II CRISPR-Cas systems
Chylinski, K., Makarova, K. S., Charpentier, E., & Koonin, E. V. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku241 · Cited by 498
Applications of the CRISPR-Cas9 system in cancer biology
Sánchez-Rivera, F. J., & Jacks, T. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3950 · Cited by 405
Zhou, H., Liu, J., Zhou, C., Gao, N., Rao, Z., Li, H., Hu, X., Li, C., Yao, X., Shen, X., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-017-0060-6 · Cited by 276
Multiple Gene Repression in Cyanobacteria Using CRISPRi
Yao, L., Cengic, I., Anfelt, J., & Hudson, E. P. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.5b00264 · Cited by 246
Shen, C., Que, Z., Xia, Y., Tang, N., Li, D., He, R., & Cao, M. (2017) · Journal of Plant Biology · doi:10.1007/s12374-016-0400-1 · Cited by 234
Web-based design and analysis tools for CRISPR base editing
Hwang, G.-H., Park, J., Lim, K., Kim, S., Yu, J., Yu, E., Kim, S.-T., Eils, R., Kim, J.-S., & Bae, S. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2585-4 · Cited by 198
Strategies for nonviral nanoparticle‐based delivery of CRISPR/Cas9 therapeutics
Chen, F., Alphonse, M., & Liu, Q. (2020) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1609 · Cited by 197
Current status and perspectives of genome editing technology for microalgae
Jeon, S., Lim, J.-M., Lee, H.-G., Shin, S.-E., Kang, N. K., Park, Y.-I., Oh, H.-M., Jeong, W.-J., Jeong, B.-R., & Chang, Y. K. (2017) · Biotechnology for Biofuels · doi:10.1186/s13068-017-0957-z · Cited by 154
High-efficiency targeted editing of large viral genomes by RNA-guided nucleases
Bi, Y., Sun, L., Gao, D., Ding, C., Li, Z., Li, Y., Cun, W., & Li, Q. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004090 · Cited by 148
Loureiro, A., & da Silva, G. J. (2019) · Antibiotics · doi:10.3390/antibiotics8010018 · Cited by 129
Xu, L., Zhao, L., Gao, Y., Xu, J., & Han, R. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1048 · Cited by 91
Transcriptional regulation with CRISPR-Cas9: principles, advances, and applications
Didovyk, A., Borek, B., Tsimring, L., & Hasty, J. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.06.003 · Cited by 90
Shen, Q., Ruan, H., Zhang, H., Wu, T., Zhu, K., Han, W., Dong, R., Ming, T., Qi, H., & Zhang, Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1375120 · Cited by 38
Systematic and scalable genome-wide essentiality mapping to identify nonessential genes in phages
Piya, D., Nolan, N., Moore, M. L., Ramirez Hernandez, L. A., Cress, B. F., Young, R., Arkin, A. P., & Mutalik, V. K. (2023) · PLOS Biology · doi:10.1371/journal.pbio.3002416 · Cited by 31
Pandey, M., Ojha, D., Bansal, S., Rode, A. B., & Chawla, G. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.101003 · Cited by 23
A single plasmid based CRISPR interference in Synechocystis 6803 – A proof of concept
Kirtania, P., Hódi, B., Mallick, I., Vass, I. Z., Fehér, T., Vass, I., & Kós, P. B. (2019) · PLOS ONE · doi:10.1371/journal.pone.0225375 · Cited by 22
Christi, K., Hudson, J., & Egan, S. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127729 · Cited by 8
Metadata
- Authors
- Bikard, D., Jiang, W., Samai, P., Hochschild, A., Zhang, F., & Marraffini, L. A.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-06-12
- Volume
- 41
- Issue
- 15
- Pages
- 7429-7437
- ISSN
- 1362-4962
- 0305-1048
- PMC
- PMC3753641
- Cited by
- 1,145
- References
- 9
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review